Samsung Biologics

Samsung Biologics Secures Land Equivalent to 26 Soccer Fields in Songdo…To Produce ADCs and Other Advanced Therapies

Samsung Biologics is significantly expanding its handling of next-generation therapeutics as it strengthens the growth engine of its…

Park Pyeongtak

2025-12-01

Samsung Biologics to Spin Off Biosimilar Unit, Launching a Two-Track Strategy

Samsung Group’s biopharmaceutical business is being reorganized into two separate tracks: CDMO (Contract Development and Manufacturing Organization) and…

Cheon Okhyeon

2025-05-22

Samsung Life Science Fund Invests $10 Million in U.S. Alzheimer’s Blood Test Company

Samsung Life Science Fund is investing $10 million in a company developing technology for Alzheimer’s disease diagnostics. Samsung…

Cheon Okhyeon

2025-03-13

Samsung Biologics Lands Record $1.41 Billion CMO Deal

Samsung Biologics has started the year with a bang, signing its largest contract to date. On January 14,…

Cheon Okhyeon

2025-01-14

Samsung Biologics and LigaChem Partner to Target Global ADC Market

Samsung Biologics and LegoChem Biosciences Join Forces to Develop ADC Therapeutics. Samsung Biologics and LigaChem Biosciences announced on…

Cheon Okhyeon

2025-01-09

Samsung Life Science Fund Invests in U.S. Biotech ‘Generate Biomedicines’

Samsung announced on the 18th that it has invested in the U.S.-based biotech company Generate Biomedicines through its…

Cheon Okhyeon

2024-12-18

Samsung Biologics Breaks 5 Trillion KRW in Annual Orders for the First Time

Samsung Biologics has surpassed 5 trillion KRW in annual cumulative orders for the first time since its establishment.…

Cheon Okhyeon

2024-11-20

Strong Performance Drives Samsung Biologics’ Price Target Upward

Following Samsung Biologics’ announcement of its third-quarter results, several securities firms have raised their target stock price for…

Cheon Okhyeon

2024-10-24

Samsung Biologics Secures Record 1.7 Trillion KRW Contract

Samsung Biologics has made headlines again. On the 22nd, the company announced that it had signed a massive…

Cheon Okhyeon

2024-10-22

"Samsung Biologics Poised for Growth with Plant 5 and Biosecurity Law"

There is an evaluation that Samsung Biologics' stock could rise in the short term if the U.S. Biosecurity…

Cheon Okhyeon

2024-10-07